Seal Shield LLC announces the new Airocide® DS air purifier, a table-top or bedside air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide® converts dangerous bacteria, virus and destructive VOCs into harmless water vapor without producing ozone or other harmful byproducts. Filter-less and energy efficient, Airocide® DS produces air that is 99.999 percent pathogen-free.
While hospitals and other healthcare facilities struggle with the spread of superbugs that contribute to fatal hospital-acquired infections, new evidence shows that "HVAC systems may actually be contributing to transmission of disease" as indicated by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE). Hospitals manage airborne infectious disease routes by relying on laminar flow diverters, room pressure differentials and HEPA filtration. HEPA filtration's effectiveness is determined by its efficiency with capturing particle sizes .3 microns and above. This is a huge gap considering that numerous pathogens are smaller than .3 microns, including MRSA (.08 um), C.Diff (.07 um), Influenza (.095 um) and Pneumonia (.15 um), to name a few. Furthermore, HEPA filters only "capture" particles and provide no eradication of pathogens.
Seal Shield's Airocide® DS filter-less technology destroys all organic matter, including bacteria and viruses less than .3 microns. In fact, Airocide's eradication capabilities extend down to the smallest organic particles in existence – gas molecules measured in angstrom units. Airocide® even reduces surface contamination by removing airborne organisms that settle on fomites. The Airocide® DS protects the environment by continuously cleaning the air 24 hours a day, every day, with none of the harmful side effects associated with UV products. As a result, Airocide® is the ideal solution to supplement traditional air handling methods in any environment.
The Seal Shield Airocide® DS is currently in stock, and is available for a limited time at a special price of $499 (regularly $799). Seal Shield's infection control products are sold through major distributors worldwide.
Seal Shield designs, develops and manufactures medical grade, infection prevention technology for hospitals and the home including air purification systems, antimicrobial products, waterproof keyboards, mice and TV remote controls.
Source: Seal Shield LLC
Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care
May 5th 2025Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.